Depressive disorders are very common and are among the leading causes of disability and excess mortality worldwide.[17]World Health Organization. Depression and other common mental disorders: global health estimates. 2017 [internet publication].
https://apps.who.int/iris/handle/10665/254610
[18]Cuijpers P, Vogelzangs N, Twisk J, et al. Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry. 2014 Apr;171(4):453-62.
https://psychiatryonline.org/doi/10.1176/appi.ajp.2013.13030325
http://www.ncbi.nlm.nih.gov/pubmed/24434956?tool=bestpractice.com
[19]Ormel J, Petukhova M, Chatterji S, et al. Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry. 2008 May;192(5):368-75.
https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/disability-and-treatment-of-specific-mental-and-physical-disorders-across-the-world/84546ECF0422282EFB55DE6689187D67
http://www.ncbi.nlm.nih.gov/pubmed/18450663?tool=bestpractice.com
[20]Zhang Z, Jackson SL, Gillespie C, et al. Depressive symptoms and mortality among US adults. JAMA Netw Open. 2023 Oct 2;6(10):e2337011.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2810363#google_vignette
http://www.ncbi.nlm.nih.gov/pubmed/37812418?tool=bestpractice.com
In people aged 15-29 years, depression is the leading cause of disability and premature death globally.
WHO: Global Health Estimates
Opens in new window In the US, major depression is the second leading cause of disability overall.[21]Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013 Aug 14;310(6):591-608.
https://www.doi.org/10.1001/jama.2013.13805
http://www.ncbi.nlm.nih.gov/pubmed/23842577?tool=bestpractice.com
Beyond the direct impact of depression itself on occupational function and quality of life, depression is associated with poorer health outcomes across several conditions.[22]Matcham F, Norton S, Scott DL, et al. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial. Rheumatology (Oxford). 2016 Feb;55(2):268-78.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710801
http://www.ncbi.nlm.nih.gov/pubmed/26350486?tool=bestpractice.com
[23]Harshfield EL, Pennells L, Schwartz JE, et al. Association between depressive symptoms and incident cardiovascular diseases. JAMA. 2020 Dec 15;324(23):2396-405.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739139
http://www.ncbi.nlm.nih.gov/pubmed/33320224?tool=bestpractice.com
[24]Choudhary P, Ronkainen J, Nedelec R, et al. The relationship of life-course patterns of adiposity with type 2 diabetes, depression, and their comorbidity in the Northern Finland Birth Cohort 1966. Int J Obes (Lond). 2022 May 13 [Epub ahead of print].
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105590
http://www.ncbi.nlm.nih.gov/pubmed/35562396?tool=bestpractice.com
It has been estimated that around 4.7% of the world’s population will experience an episode of depression in any 12-month time period.[25]Ferrari AJ, Somerville AJ, Baxter AJ, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013 Mar;43(3):471-81.
http://www.ncbi.nlm.nih.gov/pubmed/22831756?tool=bestpractice.com
One international study carried out in 2019 found that point prevalence was highest in North America (4.4% for women and 2.5% for men), lowest in the Western Pacific (2.3% for women and 1.3% for men) and intermediate in other world areas (2.8% to 3.6% for women, and 1.9% to 2.0% for men).
IHME: Global Burden of Disease (GBD)
Opens in new window In 2015, the World Health Organization (WHO) found a relatively higher 12-month prevalence than this for people living in Africa compared to in other locations globally (5.8% for women, and 4.8% for men).[17]World Health Organization. Depression and other common mental disorders: global health estimates. 2017 [internet publication].
https://apps.who.int/iris/handle/10665/254610
Other studies suggest more substantial variation in reported prevalence between countries, from 2% to 21%, depending on the particular country.[26]Gutiérrez-Rojas L, Porras-Segovia A, Dunne H, et al. Prevalence and correlates of major depressive disorder: a systematic review. Braz J Psychiatry. 2020 Nov-Dec;42(6):657-72.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678895
http://www.ncbi.nlm.nih.gov/pubmed/32756809?tool=bestpractice.com
Within Europe, prevalence rates vary substantially between countries; higher rates of prevalence have been identified in Germany, Luxembourg and Iceland, with lower rates identified in Slovakia and the Czech Republic.[27]Arias-de la Torre J, Vilagut G, Ronaldson A, et al. Prevalence and variability of current depressive disorder in 27 European countries: a population-based study. Lancet Public Health. 2021 Oct;6(10):e729-38.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460452
http://www.ncbi.nlm.nih.gov/pubmed/33961802?tool=bestpractice.com
Methodological differences are believed to account for at least some of this reported variability across populations.
Mean age of onset is 26 years in high-income countries, and 24 in low- and middle-income countries, according to World Mental Health survey data.[28]Herrman H, Patel V, Kieling C, et al. Time for united action on depression: a Lancet-World Psychiatric Association Commission. Lancet. 2022 Mar 5;399(10328):957-1022.
http://www.ncbi.nlm.nih.gov/pubmed/35180424?tool=bestpractice.com
Prevalence peaks again in later life.[29]Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119-38.
http://www.ncbi.nlm.nih.gov/pubmed/23514317?tool=bestpractice.com
Global prevalence in older adults has been estimated at 13.3%.[30]Abdoli N, Salari N, Darvishi N, et al. The global prevalence of major depressive disorder (MDD) among the elderly: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2022 Jan;132:1067-73.
http://www.ncbi.nlm.nih.gov/pubmed/34742925?tool=bestpractice.com
Prevalence may be higher amongst older people who are hospitalised or living in assisted care facilities.[31]Fiske A, Wetherell JL, Gatz M. Depression in older adults. Annu Rev Clin Psychol. 2009;5:363-89.
https://www.doi.org/10.1146/annurev.clinpsy.032408.153621
http://www.ncbi.nlm.nih.gov/pubmed/19327033?tool=bestpractice.com
About one in five nursing home residents without dementia are diagnosed with depression.[32]Fornaro M, Solmi M, Stubbs B, et al. Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis. Br J Psychiatry. 2020 Jan;216(1):6-15.
https://www.doi.org/10.1192/bjp.2019.5
http://www.ncbi.nlm.nih.gov/pubmed/30864533?tool=bestpractice.com
One systematic review looking at rates of depression in older adults globally, estimated the pooled prevalence of depression in older adults as being 31.74%, with higher rates of depression in this age group seen within developing countries (40.78%) compared to developed countries (17.05%).[31]Fiske A, Wetherell JL, Gatz M. Depression in older adults. Annu Rev Clin Psychol. 2009;5:363-89.
https://www.doi.org/10.1146/annurev.clinpsy.032408.153621
http://www.ncbi.nlm.nih.gov/pubmed/19327033?tool=bestpractice.com
Incidence in women is double the incidence in men.[27]Arias-de la Torre J, Vilagut G, Ronaldson A, et al. Prevalence and variability of current depressive disorder in 27 European countries: a population-based study. Lancet Public Health. 2021 Oct;6(10):e729-38.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460452
http://www.ncbi.nlm.nih.gov/pubmed/33961802?tool=bestpractice.com
[33]Pedersen CB, Mors O, Bertelsen A, et al. A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry. 2014 May;71(5):573-81.
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1847579
http://www.ncbi.nlm.nih.gov/pubmed/24806211?tool=bestpractice.com
People with depression experience an almost 20-fold risk of dying by suicide than do the general population.[34]Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014 Jun;13(2):153-60.
https://onlinelibrary.wiley.com/doi/10.1002/wps.20128
http://www.ncbi.nlm.nih.gov/pubmed/24890068?tool=bestpractice.com
One meta-analysis found that 31% of people in treatment for major depressive disorder had attempted suicide in their lifetime.[35]Dong M, Zeng LN, Lu L, et al. Prevalence of suicide attempt in individuals with major depressive disorder: a meta-analysis of observational surveys. Psychol Med. 2019 Jul;49(10):1691-704.
http://www.ncbi.nlm.nih.gov/pubmed/30178722?tool=bestpractice.com
Comorbidity with other mental health conditions is common across treatment settings in both primary and secondary care, particularly with anxiety disorders, post-traumatic stress disorder and substance use disorders.[36]Kotiaho S, Korniloff K, Vanhala M, et al. Psychiatric diagnosis in primary care patients with increased depressive symptoms. Nord J Psychiatry. 2019 Apr;73(3):195-9.
http://www.ncbi.nlm.nih.gov/pubmed/30929594?tool=bestpractice.com
[37]Lamers F, van Oppen P, Comijs HC, et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2011 Mar;72(3):341-8.
http://www.ncbi.nlm.nih.gov/pubmed/21294994?tool=bestpractice.com
Men with depression are twice as likely as women to have a comorbid substance use disorder.[38]Hunt GE, Malhi GS, Lai HMX, et al. Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: systematic review and meta-analysis. J Affect Disord. 2020 Apr 1;266:288-304.
http://www.ncbi.nlm.nih.gov/pubmed/32056890?tool=bestpractice.com
In patients with an affected first-degree relative, the lifetime risk of depression increases two- to threefold. First onset occurs most frequently in patients aged 12-24 years or older than 65 years.[39]Remick RA. Diagnosis and management of depression in primary care: a clinical update and review. CMAJ. 2002 Nov 26;167(11):1253-60.
http://www.ncbi.nlm.nih.gov/pubmed/12451082?tool=bestpractice.com
Depression frequently coexists with a large number of chronic physical health disorders, including chronic pain, cardiovascular disease, cancer, diabetes, chronic respiratory diseases, tuberculosis, and obesity, potentially as a result of shared risk factors and also due to the causal effect of the physical disorder on the development of depression.[40]Gold SM, Köhler-Forsberg O, Moss-Morris R, et al. Comorbid depression in medical diseases. Nat Rev Dis Primers. 2020 Aug 20;6(1):69.
http://www.ncbi.nlm.nih.gov/pubmed/32820163?tool=bestpractice.com
Dementia, by some measures, can nearly double the risk.[41]Asmer MS, Kirkham J, Newton H, et al. Meta-analysis of the prevalence of major depressive disorder among older adults with dementia. J Clin Psychiatry. 2018 Jul 31;79(5).
http://www.ncbi.nlm.nih.gov/pubmed/30085437?tool=bestpractice.com
It has been postulated that depression itself may act as a causal risk factor for the development and worsening of some chronic physical disorders.[42]Penninx BW, Milaneschi Y, Lamers F, et al. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med. 2013 May 15;11:129.
https://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-11-129
http://www.ncbi.nlm.nih.gov/pubmed/23672628?tool=bestpractice.com
[43]Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci. 2011;13(1):7-23.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181964
http://www.ncbi.nlm.nih.gov/pubmed/21485743?tool=bestpractice.com
[44]Cooney LG, Lee I, Sammel MD, et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017 May 1;32(5):1075-91.
https://academic.oup.com/humrep/article/32/5/1075/3064352
http://www.ncbi.nlm.nih.gov/pubmed/28333286?tool=bestpractice.com
[45]Arnaud AM, Brister TS, Duckworth K, et al. Impact of major depressive disorder on comorbidities: a systematic literature review. J Clin Psychiatry. 2022 Oct 19;83(6):21r14328.
https://www.psychiatrist.com/jcp/impact-major-depressive-disorder-comorbidities-systematic-literature-review
http://www.ncbi.nlm.nih.gov/pubmed/36264099?tool=bestpractice.com
The prevalence of major depressive disorder increased rapidly during the COVID-19 pandemic, particularly in younger adults.[46]Jia H, Guerin RJ, Barile JP, et al. National and state trends in anxiety and depression severity scores among adults during the COVID-19 pandemic: United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 8;70(40):1427-32.
https://www.cdc.gov/mmwr/volumes/70/wr/mm7040e3.htm
http://www.ncbi.nlm.nih.gov/pubmed/34618798?tool=bestpractice.com
[47]COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021 Nov 6;398(10312):1700-12.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02143-7/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/34634250?tool=bestpractice.com
[48]Collier Villaume S, Chen S, Adam EK. Age disparities in prevalence of anxiety and depression among US adults during the COVID-19 pandemic. JAMA Netw Open. 2023 Nov 1;6(11):e2345073.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2812389#google_vignette
http://www.ncbi.nlm.nih.gov/pubmed/38032641?tool=bestpractice.com
The World Health Organization (WHO) estimates that the COVID-19 pandemic triggered a 25% increase in the prevalence of depression worldwide; the longer-term implications of this are currently unclear.[49]World Health Organization. COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide. Mar 2022 [internet publication].
https://www.who.int/news/item/02-03-2022-covid-19-pandemic-triggers-25-increase-in-prevalence-of-anxiety-and-depression-worldwide